Tradition Wealth Management’s AbCellera Biologics ABCL Stock Holding History

Tradition Wealth Management’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$361K	Sell	45,958 -1,770	-4%	-$8.65K	0.02%	376
2026 Q1	$167K	Buy	47,728 +618	+1%	+$2.22K	0.01%	485
2025 Q4	$161K	Buy	47,110 +10,972	+30%	+$49K	0.01%	468
2025 Q3	$182K	Buy	+36,138	New	+$159K	0.01%	462

Other funds holding ABCL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Tradition Wealth Management's ABCL Position: Q2 2026 in Review

Tradition Wealth Management reduced its AbCellera Biologics (ABCL) stake by 3.7% in Q2 2026, selling an estimated $8.65K and leaving 45,958 shares worth $361K. The position accounts for 0.02% of the portfolio, ranked #376.

Tradition Wealth Management first reported a position in ABCL in Q3 2025 and has held it in 4 quarters since. 150 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

Tradition Wealth Management held 45,958 shares of AbCellera Biologics worth $361K as of Q2 2026.
Tradition Wealth Management sold 1,770 AbCellera Biologics shares in Q2 2026, an estimated $8.65K.
AbCellera Biologics made up 0.02% of Tradition Wealth Management's portfolio in Q2 2026, its #376 holding.
Tradition Wealth Management first reported a position in AbCellera Biologics in Q3 2025 and has held it in 4 quarters since.
150 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Tradition Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.